Vofopitant
- Generic Name
- Vofopitant
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H23F3N6O
- CAS Number
- 168266-90-8
- Unique Ingredient Identifier
- K08BK043YS
- Background
Vofopitant has been used in trials studying the treatment of PTSD, Primary Insomnia, and Sleep Initiation and Maintenance Disorders.
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2009-05-25
- Last Posted Date
- 2017-07-21
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 12
- Registration Number
- NCT00907985
- Locations
- 🇩🇪
GSK Investigational Site, Goettingen, Niedersachsen, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath